Eva King Killam

Last updated
Eva King Killam
Born
Ellen Eva King

1920/1921
New York State
DiedJuly 30, 2006
California
Alma mater Sarah Lawrence College, Mount Holyoke College, University of Illinois
PartnerKeith Killam
Awards John J. Abel Award
Scientific career
Fields Neuropharmacology
Institutions University of California at Los Angeles, Stanford University, University of California at Davis

Eva King Killam (1920/1921 - July 30, 2006) [1] was a research pharmacologist who studied the activity of drugs on the brain and behavior, developing animal models for epilepsy and opiate dependence. [2]

Contents

Killam was the first woman to be awarded the John J. Abel Award in Pharmacology from the American Society for Pharmacology and Experimental Therapeutics (ASPET) in 1954, and the second woman to be elected as president of ASPET, in 1989. [3] [4] A founding member of the American College of Neuropsychopharmacology (ACNP) in 1961, she became the first woman President of the ACNP in 1988. [1]

Early life and education

Ellen Eva King [5] was a daughter of Charles Henry King and Louise M. Richter. She had a sister Louise and an older brother, Charles, Jr. [6] who worked for NASA. [7] Eva grew up in Eastchester, New York. She graduated from Sarah Lawrence College [1] with a bachelor's degree [2] in 1942, and from Mount Holyoke College with a master's degree in zoology [2] in 1944. [8]

She spent a year in the Ph.D. program at Yale University, studying zoology, but returned home due to her father's illness. [9] Working as a pharmacologist at the Burroughs-Wellcome Laboratories convinced her to study pharmacology. [9]

She spent three years working as a pharmacologist for the Army Chemical Center with Amedeo S. Marazzi [9] [5] before doing doctoral work in pharmacology at the medical school of the University of Illinois in Chicago, Illinois. [2] There she worked with Klaus Unna  [ de ] and met her future husband, Keith Killam. [9] She received her degree from the University of Illinois in 1953. [8] [10] She was the first woman to receive a Ph.D. from the program. [11]

Career

In 1953, [1] Eva King joined the University of California at Los Angeles (UCLA) to do postdoctoral work with Horace Winchell Magoun [9] at the UCLA Brain Research Institute. [1] She began studying the effects of chlorpromazine. [9]

In 1955, Eva King and Keith Killam married in Santa Monica, California. [2] [12] Until her retirement in 1991, [13] Eva and her husband were frequent co-investigators. [3]

In 1959, the Killams moved to Stanford University. At Stanford, Keith became an associate professor of pharmacology while Eva worked as a research associate. [3]

In 1968, the Killams joined the University of California at Davis. [3] They moved to the University of California at Davis because they could establish a primate center there. [9] Keith was the founding chair of the Department of Pharmacology, while Eva was first a professor of physiology (1968-1972), and then a professor of pharmacology (1972-). [3]

A founding member of the American College of Neuropsychopharmacology (ACNP) in 1961, Killam became the first woman President of the ACNP in 1988. [1]

In 1989 Eva King Killam became the second female president of the American Society for Pharmacology and Experimental Therapeutics (ASPET), following Marjorie Horning (1984). Killam had previously served as the first female Councillor of the organization (1973-1976). [3]

Killam also served as president of the Western Pharmacology Society [3] which she and her husband had helped to found. [1]

Killam served on the Task Force on Support of Training and Research in Pharmacology, part of the President's Biomedical Research Panel, in 1976. [14] Killam was the first woman editor-in-chief of the Journal of Pharmacology and Experimental Therapeutics , serving from 1978-1991. [3] She also edited Pharmacological Reviews . [1]

Research

Killam published more than 150 papers in refereed journals, many studying the activity of drugs on neural mechanisms in the areas such as the extrapyramidal motor system, the hippocampus, and the brainstem reticular formation. She made single neuron cell recordings to study the impact of substances on neuronal electrical firing rates. [9] Behaviorally, she studied effects on sleep, wakefulness, and learning. Killam also studied pharmacological control of epilepsy, anticonvulsants and their effects on learning. [2]

The Killams spent a sabbatical in Marseilles, France in 1965 or 1966 with Robert Naquet, [9] and discovered that baboons suffered from a type of epilepsy. [1] [15] [16] [17] After returning to the United States, they set up their own lab, and used their animal model of epilepsy to develop a screening test for anticonvulsants. [9] They were able to examine which drugs worked and where they worked in the brain. They also assessed the behavioral toxicity of potential anti-epileptic drugs and the likelihood that they would affect learning. The baboon research also demonstrated the genetic basis underlying epileptic events, which were inherited in baboons following a strictly Mendelian pattern. Keith credits Eva with doing the majority of the work on baboons and learning. [9]

Later in their careers, they developed an animal model in morphine-dependent Rhesus monkeys with implications for opiate dependence [18] and HIV/AIDS research. They found that a virus similar to the one that causes HIV in humans replicated three times as often in morphine-dependent monkeys as compared to monkeys not exposed to morphine. Mutation rates of the virus were higher and the new mutations were AZT insensitive. [9]

Awards and honors

In 1954, Eva King was the first woman to receive the John J. Abel Award for research in neuropsychopharmacology from the American Society for Pharmacology and Experimental Therapeutics (ASPET). [3] [4] The next woman to receive the award was Lee Limbird in 1987, 33 years later. The third was Susan Amara in 1993. [3]

In 2002, Eva King Killam received the Paul Hoch Distinguished Service Award from tne American College of Neuropsychopharmacology. [19] [20]

The American College of Neuropsychopharmacology has named the Eva King Killam Research Award after her. [21] The award was first given in 2011. [22]

Related Research Articles

The International Union of Basic and Clinical Pharmacology (IUPHAR) is a voluntary, non-profit association representing the interests of scientists in pharmacology-related fields to facilitate Better Medicines through Global Education and Research around the world.

<i>Journal of Pharmacology and Experimental Therapeutics</i> Academic journal

The Journal of Pharmacology and Experimental Therapeutics is a peer-reviewed scientific journal covering pharmacology. It has been published since 1909 by the American Society for Pharmacology and Experimental Therapeutics (ASPET). The journal publishes mainly original research articles, and accepts papers covering all aspects of the interactions of chemicals with biological systems.

The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a scientific society founded in late 1908 by John Jacob Abel of Johns Hopkins University, with the aim of promoting the growth of pharmacological research. Many society members are researchers in basic and clinical pharmacology who help develop disease-fighting medications and therapeutics. ASPET is one of the constituent societies of the Federation of American Societies for Experimental Biology (FASEB). The society's headquarters are in Rockville, MD. The current president is Michael F. Jarvis.

Michael J. Kuhar, is an American neuroscientist, author, and Candler Professor of Neuropharmacology at The Yerkes National Primate Research Center of Emory University. He is a Georgia Research Alliance eminent scholar, and a senior fellow in the Center for Ethics at Emory. He was previously a professor at Johns Hopkins University School of Medicine and branchchief at the National Institute on Drug Abuse.

Founded in 1961, the American College of Neuropsychopharmacology (ACNP) is a professional organization of leading brain and behavior scientists. The principal functions of the college are research and education. Their goals in research are to offer investigators an opportunity for cross-disciplinary communication and to promote the application of various scientific disciplines to the study of the brain's effect on behavior, with a focus on mental illness of all forms. Their educational goals are to encourage young scientists to enter research careers in neuropsychopharmacology and to develop and provide accurate information about behavioral disorders and their pharmacological treatment.

The John J. Abel Award is an annual award presented by the American Society for Pharmacology and Experimental Therapeutics (ASPET). The award is given for outstanding research in the field of pharmacology and/or experimental therapeutics; which comes with a $5000 prize, An engraved plaque, and all travel expenses paid to attend the ASPET Annual Meeting at Experimental Biology. The Award is named after American biochemist and pharmacologist, John Jacob Abel.

<span class="mw-page-title-main">Carl Faingold</span>

Carl L. Faingold, Ph.D. is a neuroscientist, a Distinguished Professor in the Department of Pharmacology of Southern Illinois University School of Medicine in Springfield, Illinois; he is a founding faculty member of both the department and the School of Medicine. He has had an extensive career as a medical and graduate student educator as well as a researcher into brain mechanisms. He is a specialist in the actions of drugs on brain activity at the level of the single neuron as it relates to networks of neurons in awake behaving animals.

<span class="mw-page-title-main">Louise Pearce</span> American pathologist (1885–1959)

Louise Pearce was an American pathologist at the Rockefeller Institute who helped develop a treatment for African sleeping sickness (trypanosomiasis). Sleeping sickness was a fatal epidemic which had devastated areas of Africa, killing two-thirds of the population of the Uganda protectorate between 1900 and 1906 alone. With chemists Walter Abraham Jacobs and Michael Heidelberger and pathologist Wade Hampton Brown, Pearce worked to develop and test arsenic-based drugs for its treatment. In 1920, Louise Pearce traveled to the Belgian Congo where she designed and carried out a drug testing protocol for human trials to establish tryparsamide's safety, effectiveness, and optimum dosage. Tryparsamide proved successful in combating the fatal epidemic, curing 80% of cases.

<span class="mw-page-title-main">Susan Amara</span> American neuroscientist

Susan G. Amara is an American professor of neuroscience and is the Scientific Director of the National Institute of Mental Health. Dr. Amara is an elected member of the National Academy of Sciences and a fellow of the American Association for the Advancement of Science. She is a Past-President of the Society for Neuroscience. Dr. Amara has a B.S. in Biological Sciences from Stanford University and a Ph.D. in Physiology and Pharmacology from the University of California, San Diego.

Michel Bouvier is a Canadian biochemist and molecular pharmacologist. He is a professor of biochemistry and molecular medicine at Université de Montréal; a principal investigator and the chief executive officer at the Institute for Research in Immunology and Cancer; and an associate vice-president in Research, Scientific Discovery, Creation, and Innovation at Université de Montréal. His work focuses on the study of cell signaling towards the discovery of new pharmaceutical drugs.

<span class="mw-page-title-main">Salomon Z. Langer</span>

Salomon Zender Langer is an Argentinian pharmacologist whose family had fled from Poland to Argentina in the early 1930s and were thus saved from the Holocaust during the Second World War.

Nancy Rutledge Zahniser was an American pharmacologist, best known for her work involving the mechanism of dopaminergic pathways and chemical modifications of them. Although born in Ann Arbor, Michigan, Zahniser grew up in Chillicothe, Ohio and subsequently enrolled at the College of Wooster, where she obtained a degree in chemistry. After completing her degree, Zahniser spent some time in India where she met her first husband Mark Zahniser; she later returned to the United States to attend the University of Pittsburgh School of Pharmacy, where she earned her PhD in pharmacology in 1977. Zahniser went on to complete her post-doctoral training at the University of Colorado Health Sciences Center's Department of Pharmacology and then became a part of the faculty there. In 2007, she became associate dean for research education. She played a role in advancing the careers of many post-doctoral students in her lab. In addition to her work as a professor, Zahniser was also a member of several boards, committees, review panels, and professional societies related to pharmacology, neuroscience, and addiction. She led several national research meetings from 1995-2002.

Marjorie Janice Groothuis Horning was an American biochemist and pharmacologist. She was considered to be a pioneer of chromatography for her work in developing new techniques and applying them to the study of drug metabolism. She demonstrated that drugs and their metabolites can be transferred from a pregnant woman to her developing child, and later through breast milk, from a mother to a baby. Horning's work made possible the prevention of birth defects, as doctors began to warn of the dangers of drugs, alcohol, and smoking during pregnancy.

Marion Sewer (1972-2016) was a pharmacologist and professor at the University of California, San Diego's Skaggs School of Pharmacy and Pharmaceutical Sciences known for her research on steroid hormone biogenesis and her commitment to increasing diversity in science. Much of her research centered around cytochrome P450, a family of enzymes involved in the conversion of cholesterol into steroid hormones. She died unexpectedly at the age of 43 from a pulmonary embolism on January 28, 2016, while traveling through the Detroit airport.

<span class="mw-page-title-main">Namandjé Bumpus</span> American pharmacologist

Namandjé N. Bumpus is an American pharmacologist and the Chief Scientist of the Food and Drug Administration. She was previously director of the department of pharmacology and molecular sciences at Johns Hopkins University School of Medicine, where she holds the E.K. Marshall and Thomas H. Maren professorship in pharmacology. Bumpus is known for her research on the metabolism of antiviral drugs used to treat HIV-1 and how genetic variations in drug-processing enzymes may impact these drugs' efficacy. Bumpus received a Presidential Early Career Award for Scientists and Engineers in 2016.

Joan Heller Brown is an American pharmacologist. She is Distinguished Professor and Chair of the Department of Pharmacology at UC San Diego School of Medicine. She is known for fundamental contributions to the understanding of G-protein coupled receptors (GPCRs) — molecules that span cell membranes, where they transmit messages between cells and their environments — and how GPCRs regulate cell growth and survival, in healthy and various disease states. Many therapeutic drugs work by influencing GPCRs, thus Heller Brown's discoveries have been crucial to their development.

Dr. Dolores C. Shockley was the first black woman to receive a PhD in pharmacology in the United States and one of the first African American students to receive a PhD from Purdue University. After obtaining her PhD she became faculty at the historically black school Meharry Medical College where she subsequently became the first black woman to chair a Pharmacology department in the United States in 1988. Her research contributions included studying the effects of chemical pollutants on the brain and identifying pharmacological agents that interact with drugs of abuse such as cocaine. She was a distinguished scholar and emeritus professor at Meharry Medical College.

<span class="mw-page-title-main">Carolyn I. Rodriguez</span> Puerto Rican psychiatrist, neuroscientist, and clinical researcher

Carolyn I. Rodriguez is a Puerto Rican psychiatrist, neuroscientist, and clinical researcher developing treatments for obsessive compulsive disorder as well as mapping circuit dysfunction in the human brain. Rodriguez holds appointments in both clinical and academic departments at Stanford University. Rodriguez is a Clinical Lab Director at the Stanford Center for Cognitive and Neurobiological Imaging, an associate professor and Associate Chair of Psychiatry and Behavioral Sciences, and a Director of several specialized translational research programs.

Lee Limbird is a pharmacologist, Dean of the School of Natural Science, Mathematics and Business & Professor in the Department of Life and Physical Sciences at Fisk University, Nashville, Tennessee.

John Stephen Lazo is an American pharmacologist noted for his work discovering the fundamental mechanisms of action of small molecule therapeutics and the factors that confer drug resistance. He is a professor emeritus of pharmacology at University of Virginia.

References

  1. 1 2 3 4 5 6 7 8 9 Spector, Sydney (April 2007). "Eva King Killam, 1920–2006". Neuropsychopharmacology. 32 (4): 974. doi: 10.1038/sj.npp.1301298 . ISSN   1740-634X. S2CID   36822514 . Retrieved 13 April 2022.
  2. 1 2 3 4 5 6 "Memorial Travel Award Fund". American Society for Pharmacology and Experimental Therapeutics. Retrieved 13 April 2022.
  3. 1 2 3 4 5 6 7 8 9 10 Cohen, Marlene L.; Brevig, Holly; Carrico, Christine; Wecker, Lynn (2007). "SPECIAL CENTENNIAL ARTICLE Women in ASPET: A Centennial Perspective" (PDF). The Pharmacologist. 49 (4): 124–137. Retrieved 2019-11-24.
  4. 1 2 "PREVIOUS WINNERS OF SOCIETY AWARDS". American Society for Pharmacology and Experimental Therapeutics. 2009. Retrieved 12 April 2022.
  5. 1 2 King, Ellen Eva; Marrazzi, Amedeo S. (30 November 1952). "Limiting Effect of Adrenaline on Output of Adrenal Medulla". American Journal of Physiology. Legacy Content. 171 (3): 612–623. doi:10.1152/ajplegacy.1952.171.3.612. ISSN   0002-9513. PMID   13016810 . Retrieved 13 April 2022.
  6. ↑ "Charles H. King Jr. Obituary". The Washington Post. October 15, 2010. Retrieved 13 April 2022.
  7. ↑ "Charles Henry King Junior | National Air and Space Museum". Smithsonian Air and Space Museum. Retrieved 13 April 2022.
  8. 1 2 UNIVERSITY OF ILLINOIS TRANSACTIONS OF THE BOARD OF TRUSTEES July 1, 1952, to June 30, 1954. UIHistories Project Repository: University of Illinois. 1953. p. 723. Retrieved 13 April 2022.
  9. 1 2 3 4 5 6 7 8 9 10 11 12 Ban, Thomas A.; Fink, Max, eds. (2011). An oral history of neuropsychopharmacology : the first fifty years : peer interviews (PDF). Brentwood, Tennessee: ACNP. ISBN   9781461161455 . Retrieved 13 April 2022.
  10. ↑ King, Ellen Eva (1 January 1953). "THE LINGUOMANDIBULAR REFLEX, A NEUROPHYSIOLOGICAL AND NEUROPHARMACOLOGICAL STUDY". University of Illinois at Chicago. Retrieved 13 April 2022.
  11. ↑ Henderson, Metta Lou; Worthen, Dennis B. (8 March 2002). American Women Pharmacists: Contributions to the Profession. CRC Press. p. 166. ISBN   978-0-7890-1092-6 . Retrieved 13 April 2022.
  12. ↑ "Ellen E. King Is Bride Of Dr. K. F. Killam". Bronxville Review Press and Reporter. 19 May 1955. Retrieved 13 April 2022. Miss Ellen Eva King, daughter of Mrs. Charles H. King of 42 Parkway Road, Bronxville, became the bride of Dr. Keith F. Killam Jr, son of Mr. and Mrs. Killam of Newton, Mass., at a ceremony performed May 12 in Santa Monica, Calif. Both the bride and her husband are on the faculty of the Medical School, University of California. They will live in Santa Monica. Mrs. Killam, daughter of the late Charles H. King, was graduated from the Bronxviile School and Sarah Lawrence College, and received her Master's degree from Mount Holyoke College and her Ph.D. degree in pharmacology at the Graduate Professional College of the University of Illinois, where her husband, a graduate of Tufts College, also received his Master's and Ph. D. degrees.
  13. ↑ "Celebrating our founding women in medicine: Under the Plane tree" (PDF). UC Davis School of Medicine. Retrieved 13 April 2022.
  14. ↑ Report of the President's Biomedical Research Panel: submitted to he President and the Congress of the United States. Washington, D.C.: U.S. Department of Health, Education, and Welfare, Public Health Service. 1976. p. 268. Retrieved 13 April 2022.
  15. ↑ "Medical research helps the cause of peace" (PDF). Congressional Record - House. September 11, 1967. p. 24970. Retrieved 13 April 2022.
  16. ↑ Naquet, R. (February 1972). "Photosensitive epilepsy of the baboon Papio papio". Proceedings of the Royal Society of Medicine. 65 (2): 180. doi:10.1177/003591577206500237. ISSN   0035-9157. PMC   1644133 . PMID   5085037.
  17. ↑ Killam, K. F; Killam, E. K; Naquet, R (1 June 1967). "An animal model of light sensitive epilepsy". Electroencephalography and Clinical Neurophysiology. 22 (6): 497–513. doi:10.1016/0013-4694(67)90058-2. ISSN   0013-4694. PMID   4164964 . Retrieved 13 April 2022.
  18. ↑ Burch, N. (6 December 2012). Behavior and Brain Electrical Activity. Springer Science & Business Media. ISBN   978-1-4613-4434-6 . Retrieved 13 April 2022.
  19. ↑ "2017 ACNP Paul Hoch Distinguished Service Award" (PDF). American College of Neuropsychopharmacology. Retrieved 13 April 2022.
  20. ↑ "Paul Hoch Previous Award Winners". American College of Neuropsychopharmacology. Retrieved 13 April 2022.
  21. ↑ "Eva King Killam Previous Award Winners". ACNP. Retrieved 13 April 2022.
  22. ↑ "Pittenger awarded 2015 ACNP Eva King Killam Research Award". medicine.yale.edu. Retrieved 13 April 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.